Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected 210 countries and territories around the world.  The virus has spread rapidly, and the disease is still extending up to now. The pathophysiology for SARS-CoV-2 has not been well elucidated, and diverse hypotheses to date have been proposed. Initially, no skin manifestations were observed among patients with COVID-19, but recently a few cases have been described. In this review, we discuss these various cutaneous manifestations, and skin problems related to personal protective equipments, as well as different cutaneous anti-COVID-19 drugs-associated reactions. We also focus on the current proposed managements of these rare manifestations.

Keywords: SARS-CoV-2, COVID-19, Cutaneous manifestations, Health-care workers, Hydroxychloroquine